Minocycline, a microglial inhibitor, reduces 'honey trap' risk in human economic exchange

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Watabe, Motoki ^a   Kato, Takahiro A ^b,c   Tsuboi, Sho ^d   Ishikawa, Katsuhiko ^c   Hashiya, Kazuhide ^c   Monji, Akira ^b   Utsumi, Hideo ^c   Kanba, Shigenobu ^b  

^a WASEDA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MINOCYCLINE;

ADULT; ARTICLE; BRAIN; DECISION MAKING; DRUG EFFECT; HUMAN; HUMAN RELATION; MALE; MICROGLIA; PHYSIOLOGY;

ADULT; BRAIN; DECISION MAKING; HUMANS; INTERPERSONAL RELATIONS; MALE; MICROGLIA; MINOCYCLINE; YOUNG ADULT;

EID: 84884246320     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01685     Document Type: Article

References (40)

1. Buss, D. M. & Schmitt, D. P. Sexual strategies theory: an evolutionary perspective on human mating. Psychol. Rev. 100(2), 204-232 (1993).
2. Mulford, M., Orbell, J., Shatto, C. & Stackard, J. Attractiveness, Opportunity, and Success in Everyday Exchange. Am. J. Sociol. 103(6), 1565-1592 (1998).
3. Takahashi, C., Yamagishi, T., Tanida, S., Kiyonari, T. & Kanazawa, S. Attractiveness and Cooperation in Social Exchange. Evol. Psychol. 4, 315-329 (2006).
4. Sofuoglu, M., Mooney, M., Kosten, T., Waters, A. & Hashimoto, K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Psychopharmacology (Berl) 213(1), 61-68 (2011).
5. Miyaoka, T. et al. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog. Neuropsychopharmacol. Biol. Pychiatry 37(2), 222-226 (2012).
6. Levkovitz, Y. et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J. Clin. Psychiatry 71(2), 138-149 (2010).
7. Miyaoka, T. et al. Minocycline as adjunctive therapy for schizophrenia: an openlabel study. Clinical neuropharmacology 31(5), 287-292 (2008).
8. Watabe, M., Kato, T. A., Monji, A., Horikawa, H. & Kanba, S. Does minocycline, an antibiotic with inhibitory effects on microglial activation, sharpen a sense of trust in social interaction? Psychopharmacology (Berl) 220(3), 551-557 (2012).
9. Kato, T. A. et al. Minocycline modulates human social decision-making: possible impact of microglia on personality-oriented social behaviors. PLoS ONE 7(7), e40461 (2012).
10. Spielberger, C. D., Gursuch, R. L. & Lushene, R. E. Manual for the State-Trait Anxiety Inventory (Self-evaluation Questionnaire) (Consulting Psychologists Press, Palo Alto, CA, 1970).
11. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T. & Koistinaho, J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95(26), 15769-15774 (1998).
12. Yrjanheikki, J. et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96(23), 13496-13500 (1999).
13. Du, Y. et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Nat.l Acad. Sci. U. S. A. 98(25), 14669-14674 (2001).
14. Dodel, R. et al. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11) C] (R)-PK11195 PET (MEMSA-trial). Mov. Disorders 25(1), 97-107 (2010).
15. Graeber, M. B. & Streit, W. J. Microglia: biology and pathology. Acta Neuropathol. 119(1), 89-105 (2010).
16. Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10(11), 1387-1394 (2007).
17. Ransohoff, R. M. & Cardona, A. E. The myeloid cellsof the central nervous system parenchyma. Nature 468(7321), 253-262 (2010).
18. Monji, A., Kato, T. & Kanba, S. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 63(3), 257-265 (2009).
19. Van Berckel, B. N. et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 64(9), 820-822 (2008).
20. Kato, T. A. et al. Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? Mini Rev. Med. Chem. 11(7), 565-574 (2011).
21. Suzuki, K. et al. Microglial activation in young adults with autism spectrum disorder. JAMA psychiatry 70(1), 49-58 (2013).
22. Morgan, J. T. et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68(4), 368-376 (2010).
23. Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R. & Maier, S. F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 21(1), 47-59 (2007).
24. Sugama, S., Takenouchi, T., Fujita, M., Conti, B. & Hashimoto, M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J. Neuroimmunol. 207(1-2), 24-31 (2009).
25. Tynan, R. J. et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 24(7), 1058-1068 (2010).
26. Neigh, G. N. et al. Anxiety after cardiac arrest/cardiopulmonary resuscitation: exacerbated by stress and prevented by minocycline. Stroke 40(11), 3601-3607 (2009).
27. Ransohoff, R. M. & Stevens, B. Neuroscience. How many cell types does it take to wire a brain? Science 333(6048), 1391-1392 (2011).
28. Graeber, M. B. Changing face of microglia. Science 330(6005), 783-788 (2010).
29. Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29(13), 3974-3980 (2009).
30. Tremblay, M. E. et al. The role of microglia in the healthy brain. J. Neurosci. 31(45), 16064-16069 (2011).
31. Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048), 1456-1458 (2011).
32. Arakawa, S. et al. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline. Pharmacol. Biochem. Behav. 100(3), 601-606 (2012).
33. Winston, J. S., Strange, B. A., O'Doherty, J. & Dolan, R. J. Automatic and intentional brain responses during evaluation of trustworthiness of faces. Nat Neurosci 5(3), 277-283 (2002).
34. Adolphs, R. What does the amygdala contribute to social cognition? Ann. NY. Acad. Sci. 1191, 42-61 (2010).
35. Kim, H. S. & Suh, Y. H. Minocycline and neurodegenerative diseases. Behav. Brain Res. 196(2), 168-179 (2009).
36. Hashimoto, K. & Ishima, T. A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI. PLoS ONE 5(11), e15430 (2010).
37. Tikka, T. M. & Koistinaho, J. E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166(12), 7527-7533 (2001).
38. Purisai, M. G. et al. Microglial activation as a priming event leading to paraquatinduced dopaminergic cell degeneration. Neurobiol. Dis. 25(2), 392-400 (2007).
39. Berg, J., Dickhaut, J. & McCabe, K. Trust, Reciprocity, and Social History. Games Econ. Behav. 10(1), 122-142 (1995).
40. Jonas, M. & Cunha, B. A. Minocycline. Ther. Drug Monit. 4(2), 137-145 (1982).